Staying active on the deal front, RTI invests in St. Louis company
Staying active on the deal front, Research Triangle Park-based research institute RTI International has invested in a St. Louis genomics company.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news
More News: Health Management | Pharmaceuticals